Motor symptoms affect movement in a variety of ways. In his first book, “Lucky Me” Michael J Fox gives a very good description of the onset of the commonest and signature symptom of PD – the tremor. He goes on to describe the dyskinesia (large involuntary movements) that usually follows. I can’t vouch for the accuracy of his description because my onset was completely different. I have neither tremor nor dyskinesia .
Motor symptoms are caused by a lack of the neurotransmitter, dopamine, that is made in the region of the brain called the substantia nigra (black stuff). The tremor cannot be treated directly with dopamine because dopamine does not pass the blood brain barrier (BBB) but it does respond to l-dopa (laevo-dihydroxyphenylalanine), the amino acid that is the natural precursor of dopamine in the brain. L-dopa is usually administered as Sinemet or Madopar, which is l-dopa together with carbidopa, a substance that slows down the conversion of l-dopa to dopamine in the body but which cannot pass the BBB. Carbidopa thus preserves the l-dopa so that it lasts longer in the body and more of it is available to the brain, and for longer, than would l-dopa be if administered alone.
Dyskinesia is a symptom not of PD but of long term (>5 years) treatment with l-dopa. From talking to PD patients and reading about it people seem to find tremor probably the most disabling symptom of PD. In the second volume of his autobiography, “Always Looking Up” Michael J Fox gives a graphic description of the effects of tremor and dyskinesia which illustrates the gap between the clinician’s and the patient’s assessment of PD. The clinician says that the outlook for early onset patients is better than for late onset patients. It is true that late onset without motor symptoms carries a larger risk of cognitive impairment but carries a smaller impact on life expectancy. I do not shake but I do have bradykinesia (slow movement) and I do not envy Michael J Fox his version of PD!.
My consultant tells me that about 30% of patients diagnosed with PD don’t have the tremor. But the peak age for PD diagnosis is 70+ and, if there is no tremor, the other symptoms can easily be attributed to old age.
A team based at University College reported some statistics on 433 individuals from the Queen Square Brain Bank for Neurological Diseases, all pathologically proven to have PD (post mortem!) of which 342 presented with motor symptoms, of whom just over two thirds were initially diagnosed with PD. Ninety one had only non-motor symptoms, of whom only 16% were initially diagnosed with PD. GPs are presented with a case of PD to diagnose only a few times in their career and one without motor symptoms only rarely, although 91/433 certainly understates what must be the real proportion of undiagnosed PD cases.
Parkinson’s UK estimated the prevalence of PD (the total number of cases diagnosed per 10000 population) in 2009. The results were presented as a histogram from which I estimated the numerical values shown in the Table 1 below. If the prevalence is less than 1% you can calculate the approximate incidence by simply subtracting the previous year’s prevalence form the prevalence in the current year as I have done.
Table 1 Actual prevalence and incidence of PD in the UK in 2009 (Parkinson’s UK)
Age |
35-39 |
40-44 |
45-49 |
50-54 |
55-59 |
60-64 |
65-69 |
70-74 |
75-79 |
80-84 |
85+ |
Prev. |
0 |
0.1 |
1.5 |
5 |
11.5 |
24 |
46 |
83 |
130 |
172 |
171 |
Incid. |
0 |
0.1 |
1.5 |
3.5 |
6.5 |
12.5 |
22 |
37 |
47 |
42 |
0 |
As the prevalence rises in older age groups this will increasingly understate the true incidence because you cannot get PD twice and the increase in PD diagnoses needed to fit the prevalence data will require a higher incidence applied to the progressively smaller number still susceptible. A further complication, but one that at least partly offsets this, is the fact that PD patients have a reduced life expectancy, which results in more PD patients dying than those who do not have it, which in turn means that the proportion of susceptible people increases relative to what it would be if PD had no effect on life expectancy. These two factors do not exactly cancel each other out because PD patients would all have to die before their PD-free contemporaries and we know that this does not happen. I’m working on a model that will do the calculations properly but this is complex (I have to interpolate data from each age band into separate age-in-years in each year and then make assumptions about the distribution of year of death for each about the mean life expectancy when the standard deviation is large…..). I could go on but you get the picture! I am not sure all these estimates and assumptions will produce a more reliable answer than a cruder approach and so I will claim an amateur statistician’s privilege to ignore two factors, each mostly small, whose effects are in opposite directions and rend to cancel each other out. For my present purposes I wish only to remark that, although it is understandable that diagnoses of PD might decline in people who are over 80 years old it seems very unlikely that the disease actually disappears abruptly when we reach the age of 80 after the incidence has increased by an average of 1.9 times every 5 years between the ages of 50 and 74. If we assume that the occurrence of PD continues to increase at the same rate after the age of 74, but the new cases are simply not diagnosed, we get the results shown in Table 2.
Table 2 Hypothetical prevalence and incidence of PD in the UK if the pattern of increase between 50 and 79 continues to age 100
Age |
35-39 |
40-44 |
45-49 |
50-54 |
55-59 |
60-64 |
65-69 |
70-74 |
75-79 |
80-84 |
85-89 |
90-94 |
95-99 |
Hypo. Incid. |
0 |
0.1 |
1.5 |
3.5 |
6.5 |
12.4 |
23.5 |
44.6 |
84.71 |
160.9 |
305.8 |
581 |
1104 |
Hypo. Prev. |
0 |
0.1 |
1.5 |
5 |
11.5 |
23.9 |
47.4 |
92 |
177 |
338 |
643 |
1224 |
2328 |
OF course this is likely to be an extreme estimate and most probably a proportion of individuals will never contract PD but from these figures we can show (Figure 1 below) the number of undiagnosed cases of PD in older age groups that this implies just to illustrate the potential scale of the problem if life expectancy continues to increase and diagnostic methods improve.
By the age of 100 23% of us would have PD. But then an even higher proportion of us, and even more of the new PD cases would also have some form of dementia that would mask or dominate PD symptoms anyway.
This may feel like a digression. If so, I apologise but I’m afraid I’m prone to digress and I think the statistics support the argument that non-tremulous PD has a higher true incidence than 30% of total PD but is under-diagnosed because PD was defined originally as The Shaking Palsy and this has, quite understandably, led generations of clinicians to see the tremor as the defining symptom of PD – to the neglect of its other, typically less distressing, symptoms. It has also, until relatively recently, biased research toward the motor symptoms although, to be fair the availability of advanced investigative techniques may have been a more important obstacle to a broader approach to developing an understanding of what goes wrong in PD.
That’s enough for this post – I’ll carry on shortly in the next post.
Meanwhile … I’m sorry that some of you may find some of the facts about PD that we have to accept are uncomfortable but facts are the only safe basis for understanding and improving our lives.
Best wishes to PD sufferers all over the world – let me know if you find any of this helpful and ask what questions worry/interest/concern you that we can try and address.